3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Lymphoma, T-Cell, Cutaneous
2
Sezary Syndrome
1
Mycosis Fungoides
1
Melanoma
1
Interventions
Peripheral Blood Stem Cell Transplantation
38
fludarabine phosphate
34
Cyclophosphamide
29
Mycophenolic Acid
25
Cyclosporine
23
Whole-Body Irradiation
22
Tacrolimus
21
Busulfan
18
Antilymphocyte Serum
17
Methotrexate
15
Radiotherapy
14
Flow Cytometry
13
Filgrastim
13
Etoposide
13
Methylprednisolone
10
Bortezomib
10
Vorinostat
9
Melphalan
9
Therapeutics
8
Psychiatric Rehabilitation
8
Polymerase Chain Reaction
8
Lenalidomide
8
Rituximab
7
Gemcitabine
7
Cord Blood Stem Cell Transplantation
6
Bexarotene
6
tanespimycin
5
fludarabine
5
aldesleukin
5
Transplantation
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sezary Syndrome
×
Doxycycline
×
Dermatologic
×
Clear all
NCT02341209
2021-04-27
CTCL
Rochester General Hospital
Phase 2
Terminated
1 enrolled